AllianceBernstein
LRMR icon

AllianceBernstein’s Larimar Therapeutics LRMR Stock Holding History

AllianceBernstein’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$284K Hold
74,530
– – ﹤0.01% 2911
2025
Q4 		$284K Hold
74,530
– – ﹤0.01% 2938
2025
Q3 		$241K Buy
74,530
+12,150
+19% +$45.6K ﹤0.01% 3020
2025
Q2 		$180K Buy
62,380
+29,320
+89% +$67.9K ﹤0.01% 3076
2025
Q1 		$71.1K Hold
33,060
– – ﹤0.01% 3098
2024
Q4 		$128K Hold
33,060
– – ﹤0.01% 3100
2024
Q3 		$217K Buy
33,060
+5,270
+19% +$42.4K ﹤0.01% 3017
2024
Q2 		$201K Buy
+27,790
New +$213K ﹤0.01% 3035
2019
Q2 		– Sell
-875
Closed -$29K – 3176
2019
Q1 		$29K Hold
875
– – ﹤0.01% 3091
2018
Q4 		$52K Buy
+875
New +$86.4K ﹤0.01% 3055
2017
Q2 		– Sell
-925
Closed -$52K – 3162
2017
Q1 		$52K Hold
925
– – ﹤0.01% 2967
2016
Q4 		$35K Hold
925
– – ﹤0.01% 3003
2016
Q3 		$37K Sell
925
-667
-42% -$30.3K ﹤0.01% 2964
2016
Q2 		$114K Buy
+1,592
New +$126K ﹤0.01% 2899
2016
Q1 		– Sell
-1,295
Closed -$98K – 2923
2015
Q4 		$98K Sell
1,295
-342
-21% -$54.9K ﹤0.01% 2849
2015
Q3 		$627K Sell
1,637
-171
-9% -$77.1K ﹤0.01% 2400
2015
Q2 		$751K Buy
1,808
+1,133
+168% +$474K ﹤0.01% 2425
2015
Q1 		$321K Buy
+675
New +$320K ﹤0.01% 2651

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AllianceBernstein's LRMR Position: Q1 2026 in Review

AllianceBernstein held its Larimar Therapeutics (LRMR) position steady in Q1 2026 at 74,530 shares worth $284K. The position accounts for ﹤0.01% of the portfolio, ranked #2911.

AllianceBernstein first reported a position in LRMR in Q1 2015 and has held it in 18 quarters since. The position peaked at $751K in Q2 2015. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • AllianceBernstein held 74,530 shares of Larimar Therapeutics worth $284K as of Q1 2026.
  • AllianceBernstein left its Larimar Therapeutics share count unchanged in Q1 2026.
  • Larimar Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2911 holding.
  • AllianceBernstein first reported a position in Larimar Therapeutics in Q1 2015 and has held it in 18 quarters since.
  • AllianceBernstein's Larimar Therapeutics position peaked at $751K in Q2 2015.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.